ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2473

Comparison Of The Two Subtypes Of Axial Spondyloarthritis Patients Fulfilling The Imaging Arm Based On Radiographic and MRI Findings

Dilek Solmaz, Servet Akar, Ismail Sari, Pinar Cetin, Fatos Onen and Nurullah Akkoc, Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Ankylosing spondylitis (AS) and spondylarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

New Axial Spondyloarthritis Classification Criteria  include an imaging arm and a clinical arm. The imaging arm includes radiographic ax-SpA patients who have radiographic sacroilitis according to modified New York criteria  and  non-radiographic (nr) ax-SpA patients who have sacroiliitis only by MRI. Although there is no doubt that radiographic and non-radiographic axSpA  have many overlapping features, it is now one of the hot topics of discussion  whether  they are different  entities.

The aim of this study was to compare the demographics and clinical characteristics between the radiographic and nr-axSpA patients fulfilling the criteria of the imaging arm.

Methods:

A local database has been used since December 2008 to register all patients fulfilling the imaging arm of AxSpA classification criteria. Data related to demographics, clinical features, disease activity, functional status, treatment were recorded.

Results:

720 patients who met the study criteria were identified. Radiographic sacroiliitis according to modified New York criteria was present in 533 patients. The remaining 187 patients were classified as nr-axSpA based on MRI findings. Demographics and clinical characteristics are summarized in Table 1. Patients with nr-axSpA had an earlier onset of symptoms and were more often females. Prevalence of extraspinal manifestations was similar in both groups, except for anterior uveitis, which was more frequently reported by the patients with radiographic axSpA. C-reactive protein levels were significantly higher in patients with radiographic sacroiliitis as compared to those with nr-AxSpA. HLA-B27 prevalence  was numerically greater among patients with radiographic axSpA , but was not  statistically significant. Disease activity measured by BASDAI, but not by ASDAS, was higher in the nr-axSpA group; BASFI scores were similar in both groups. BASMI score was higher in radiographic ax-SpA patients. While anti-TNF therapy was used more frequently by patients with radiographic sacroiliitis, DMARD use was similar in both groups.

Conclusion:

Although many demographic and clinical features are similar between the ax-SpA patients with and without radiographic sacroiliitis classified with the imaging arm, differences such as higher prevalence of females and numerically lower prevalence of HLA-B27 among patients with nr-axSpA are of interest.

Table 1. Demographics and clinical characteristics of the radiographic and non-radiographic axSpA patients.

Demographic and clinical features

Radiographic sacroiliitis

(n:533)

Non-radiographic sacroiliitis (n:187)

P

Age, mean ± SD

43 ± 12.0

42 ± 13.2

0.232

Male sex n,%

395, 74.1

72, 38.5

<0.001

Age at beginning of the symptoms, mean ± SD

25 ± 9.1

28 ± 10.3

0.010

Diagnostic delay, mean ± SD

8 ± 8.5

7 ± 8.0

0.023

Arthritis n,(%)

195, (36.6)

42, (22.5)

0.491

Hip replacement n,(%)

23, (4.3)

0

0.023

Anterior uveitis n,%

97, (18.2)

10, (5.3)

0.007

Psoriasis n,%

16, (3.0)

4, (2.1)

0.399

IBD n,%

16, (3.0)

2, (1.0)

0.082

HLA B27 positivity n1/n2 (%)

166/243 (68.3)

46.3 % (36/78)

0.146

CRP mg/dl , mean ± SD

19.0 ± 25.6

9.5 ±17.1

<0.001

BASDAI, mean ± SD

3.5 ± 2.2

4.3 ± 2.5

<0.001

ASDAS-CRP, mean ± SD

2.9 ±1.1

2.1 ±1.1

0.223

BASFI, mean ± SD

2.9 ±2.6

2.7 ±2.5

0.346

BASMI, mean ± SD

3.9 ±1.9

2.3 ±1.0

<0.001

SSZ, n, (%)

132, (24.2)

21, (11.2)

0.316

MTX, n, (%)

34, (6.3)

4, (2.1)

0.317

Anti TNF , n,(%)

103, (19.3)

8, (4.2)

<0.001


Disclosure:

D. Solmaz,
None;

S. Akar,
None;

I. Sari,
None;

P. Cetin,
None;

F. Onen,
None;

N. Akkoc,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-the-two-subtypes-of-axial-spondyloarthritis-patients-fulfilling-the-imaging-arm-based-on-radiographic-and-mri-findings/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology